While molecular profiling particularly EGFR mutation analysis has transformed therapeutic approaches, the role of viral oncogenesis, such as human papillomavirus (HPV) infection and Epstein-Barr virus (EBV), in NSCLC is less well understood. Here, EGFR is linked to non-small cell lung carcinoma.